A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home

Completed

• Conditions: COVID-19 and Corona infection; 10047438; 10024970

• Registration Number: NL-OMON54917
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 2022-09-28
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1) Age *40 years
2) Cardiovasculair risk profile or cardiovascular disease (overweight,
hypertension, diabetes, smoking, coronary artery disease, previous myocardial
infarction, heart failure)
3) Presumably COVID-19 (both SARS-CoV-2 positive and non-COVID-19 confirmed
patients)
4) Moderate-severe symptoms
5) Mentally competent

Exclusion Criteria

1) Severe illness requiring hospital admission
2) Patient does not want future hospitalisation
3) Known anemia
4) Inadequate mastery of the Dutch language
5) Not willing to sign informed consent
6) Not willing to adhere to study procedures

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Feasibility defined as successful inclusion of 50 participants within 6 months.</p><br>